Vimarsana
Biggest News Aggregation in the World

Page 16 - Research Database News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research Database. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Database Today - Breaking & Trending Today

Study reveals sex-based differences in the clinical outcomes of COVID-19 in the US - Vimarsana News

Study reveals sex-based differences in the clinical outcomes of COVID-19 in the US

Researchers investigated sex-based differences among COVID-19 patients in the United States.

Exploring changes in non-COVID-19 hospitalization rates before and during COVID-19 - Vimarsana News

Exploring changes in non-COVID-19 hospitalization rates before and during COVID-19

Researchers assessed the trends in non-COVID-19 hospitalizations before and during the COVID-19 pandemic in the United States between 2017 and 2021.

5 Challenges AI and Analytics are Poised to Transform - Vimarsana News

5 Challenges AI and Analytics are Poised to Transform

Five socioeconomic areas that AI and analytics will address in 2022: Infrastructure, fraud, climate change, physical and mental health, and public safety.

Braxia Scientific Reports Q3 2022 Financial Results; Company Leads in Psychedelic Research, Access and Therapist Training with First Multi-Dose Psilocybin Trial in Canada - Vimarsana News

Braxia Scientific Reports Q3 2022 Financial Results; Company Leads in Psychedelic Research, Access and Therapist Training with First Multi-Dose Psilocybin Trial in Canada

Achieved milestone with the start of landmark psilocybin clinical trial in Q3 2021- more than a dozen patients receive initial dose to date in first-ever...

Braxia Scientific Reports Q3 2022 Financial Results; Company Leads in Psychedelic Research, Access and Therapist Training with First Multi-Dose Psilocybin Trial in Canada - Vimarsana News

Braxia Scientific Reports Q3 2022 Financial Results; Company Leads in Psychedelic Research, Access and Therapist Training with First Multi-Dose Psilocybin Trial in Canada

Achieved milestone with the start of landmark psilocybin clinical trial in Q3 2021- more than a dozen patients receive initial dose to date in first-ever...